Erbitux 100
Drug Category |
|
Medicinal form |
Vials |
Active ingredient |
|
Concentration |
100mg |
Manufacturer |
|
Price |
3026 EGP |
Uses
is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR). It is used in metastatic colorectal cancer , either with irinotecan in patients refractory to irinotecan-based chemotherapy, or as monotherapy. Cetuximab with radiotherapy is also approved for the ttt of locally advanced squamous cell cancer of the head and neck.
Dosage:250m ./m2/week.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies